Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

166
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
166
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network.

Journal of neurology·2021
Same author

Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes.

European stroke journal·2021
Same author

Cerebellar rTMS in PSP: a Double-Blind Sham-Controlled Study Using Mobile Health Technology.

Cerebellum (London, England)·2021
Same author

Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2021
Same author

Spontaneous cervical artery dissection and fibromuscular dysplasia: Epidemiologic and biologic evidence of a mutual relationship.

Trends in cardiovascular medicine·2021
Same author

Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia.

Stroke·2021

Related Experiment Video

Updated: Sep 13, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Clinical prediction models using artificial intelligence approaches in dementia.

Nicola Veronese1,2,3, Francesco Bolzetta4, Livia Gallo4

  • 1Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Via del Vespro, 141, 90127, Palermo, Italy. nicola.veronese@unipa.it.

Aging Clinical and Experimental Research
|July 27, 2025
PubMed
Summary

Artificial intelligence (AI) models show promise for early dementia detection, achieving good predictive accuracy. Further research is needed to address external validation and data representativeness for clinical integration.

Keywords:
Artificial intelligenceClinical prediction modelsDementiaMachine learning

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Related Experiment Videos

Last Updated: Sep 13, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Area of Science:

  • Neurology
  • Medical Informatics
  • Machine Learning

Background:

  • Nearly half of dementia cases are potentially preventable, highlighting the need for early detection and intervention.
  • Artificial intelligence (AI)-enhanced clinical prediction models leverage machine learning (ML) to integrate diverse data for improved dementia diagnosis and prognosis.
  • This systematic review assesses AI-based prediction models for dementia development, performance, and clinical use.

Purpose of the Study:

  • To systematically review and evaluate the development, performance, and clinical applicability of AI-based prediction models in dementia.
  • To assess the accuracy, bias, and generalizability of AI models for predicting dementia onset.

Main Methods:

  • Systematic literature search of PubMed, Embase, and Web of Science up to October 2024 for AI models predicting dementia onset.
  • Assessment of 21 included studies (over 1 million participants) using PROBAST for accuracy, bias, and generalizability.
  • Data extraction followed TRIPOD and CHARMS frameworks, focusing on study design, demographics, predictors, and performance metrics.

Main Results:

  • AI models demonstrated good predictive accuracy (mean AUC 0.845) across diverse datasets.
  • Machine learning methods like random forests and support vector machines outperformed traditional models.
  • Internal validation was common, but external validation was limited; calibration and generalizability remain challenges.

Conclusions:

  • AI-based prediction models offer significant potential for early dementia detection and personalized care strategies.
  • Clinical integration requires addressing external validation, data representativeness, and model interpretability.
  • Future research should prioritize robust validation and ethical considerations for optimal dementia care implementation.